title: Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem.
authors.forename: S
authors.initials: S
authors.lastname: Padol
authors.forename: Y
authors.initials: Y
authors.lastname: Yuan
authors.forename: M
authors.initials: M
authors.lastname: Thabane
authors.forename: I T
authors.initials: IT
authors.lastname: Padol
authors.forename: R H
authors.initials: RH
authors.lastname: Hunt
mesh_terms: D000897:Anti-Ulcer Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics* / Q000378:metabolism; D065731:Cytochrome P-450 CYP2C19; D016480:Helicobacter pylori / Q000187:drug effects*; D006899:Mixed Function Oxygenases / Q000235:genetics* / Q000378:metabolism; D011110:Polymorphism, Genetic; D054328:Proton Pump Inhibitors
chemical_list: D000897:Anti-Ulcer Agents; D054328:Proton Pump Inhibitors; D006899:Mixed Function Oxygenases; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19